Top Markets
#1 Siren Siren +45.30%
#2 Helium Helium +15.28%
#3 Cryptopia Cryptopia +7.69%
#4 Verus Coin Verus Coin +6.66%
#5 Useless Coin Useless Coin +5.82%
#6 0G 0G +5.13%
#7 OpenGradient OpenGradient +4.98%
#8 PondCoin PondCoin +4.47%
#9 Yield Basis Yield Basis +4.30%
#10 Ontology Gas Ontology Gas +4.18%
Coin of the day
Siren Siren
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Cybin Inc. Common Stock Cybin Inc. Common Stock

Cybin Inc. Common Stock

HELP
Rangering i aksjer #11956
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Aksjekurs
$10.30
Sist synkronisert: 2026-08-11
Markedsverdi
$638.32M
Endring (1 dag)
2.88%
Endring (1 år)
-
Land
CA
Handel Cybin Inc. Common Stock (HELP)

Kategori

Healthcare
P/S-forhold for Cybin Inc. Common Stock (HELP)
P/S-forhold per 2026 TTM: 0
Ifølge Cybin Inc. Common Stock sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Cybin Inc. Common Stock fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH